Sichuan Qingmu Pharmaceutical Co., Ltd.
Overview
Sichuan Qingmu Pharmaceutical Co., Ltd. is a pharmaceutical company based in China, founded in 2011, with 201-500 employees.
Active pharmaceutical ingredients supplied
Substances Sichuan Qingmu Pharmaceutical Co., Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Sichuan Qingmu Pharmaceutical Co., Ltd. holds 11 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- LEMBOREXANTActive2026-03-30
- NALOXONEActive2025-07-11
- LENVATINIB MESYLATEActive2025-03-24
- SUGAMMADEX SODIUMActive2024-07-24
- METHYLENE BLUEActive2024-04-15
- SILODOSINActive2023-09-14
- ROTIGOTINEActive2023-05-31
- NICARDIPINE HYDROCHLORIDEActive2022-08-28
- NALMEFENE HYDROCHLORIDEActive2022-03-21
- DABIGATRAN ETEXILATE MESYLATEActive2021-12-29
- TICAGRELORActive2019-11-06
- APIXABAN UREAInactive2023-08-14
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Sichuan Qingmu Pharmaceutical Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Sichuan Qingmu Pharmaceutical Co., Ltd.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.